Skip to content

BCTX

BriaCell Therapeutics Corp.

NASDAQ · Healthcare · Biotechnology · CA

$3.57
+1.13%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+13.1%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
May 20, 2024Lustig Marc · director, 10 percent owner: Purchase902,935$2.21
Dec 28, 2022Bondarenko Jamieson · officer: ChairmanPurchase28,000$4.58
Dec 28, 2022Williams William V. · officer: President, CEOPurchase2,530$1.94
Dec 20, 2022Bondarenko Jamieson · directorPurchase22,000$5.35
Institutional positioning

13F filings over the trailing two quarters

New 6Increased 1Reduced 3Sold out 16
FilerActionSharesFiled
CABLE CAR CAPITAL LLCNew Position216,821May 15, 2026
SABBY MANAGEMENT, LLCNew Position73,915May 15, 2026
IRIDIAN ASSET MANAGEMENT LLC/CTNew Position65,000Apr 24, 2026
LuminArx Capital Management LPNew Position15,000May 14, 2026
UBS GROUP AGIncreased11,541May 5, 2026
MORGAN STANLEYReduced3,021May 15, 2026
NATIONAL BANK OF CANADA /FI/New Position802May 15, 2026
FEDERATION DES CAISSES DESJARDINS DU QUEBECReduced455May 14, 2026
ROYAL BANK OF CANADAUnchanged100May 15, 2026
ALLWORTH FINANCIAL LPUnchanged100May 15, 2026
TD WATERHOUSE CANADA INC.Unchanged19May 12, 2026
GROUP ONE TRADING, L.P.Reduced16May 13, 2026
FNY Investment Advisers, LLCUnchanged10Apr 15, 2026
CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTDNew Position7May 11, 2026
HHM WEALTH ADVISORS, LLCUnchanged6Apr 17, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing May 20, 2024